General Mills grows into pet supplement business with acquisition of Fera Pets Inc.
General Mills Inc. (GIS) said Thursday it agreed to pay an undisclosed amount to buy Fera Pets Inc., as it moves into the pet supplement market. General Mills said it acquired Fera Pets through a newly-launched growth equity fund as part of its Gold Medal Ventures effort. John Parrish, vice president, Disruptive Growth, General Mills, said, "The pet wellbeing category is on the rise as more families look to take care of their pets the same way they take care of their own health." 301 INC, which sources investment opportunities for the General Mills growth equity fund, has invested in pollination specialist BeeHero, a direct-to-consumer cat food brand called Smalls, and a pasta brand called Carbe Diem. General Mills stock is down 22% in 2023, compared with a 14.2% rise by the S&P 500 .
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
11-09-23 0820ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks